SAEVA Proceedings 2014 | Page 55

46TH  ANNUAL  CONGRESS  OF  THE  SAEVA        SKUKUZA      16-­‐20  FEBRUARY  2014   55     2. Théon AP, Wilson WD, Magdesian KG, Pusterla N, Snyder JR, Galuppo LD “Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995–2004)” J Am Vet Med Assoc 2007; 230 (10):1506–1513. 3. Tamzali Y, Borde L, Rols MP, Golzio M, Lyazrhi F, Teissie J “Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases.” Eq Vet J 2012; 44(2); 214-20. 4. Théon AP, Pascoe JR, Carlson GP, Krag DN “Intratumoral chemotherapy with cisplatin in oily emulsion in horses.” J Am Vet Med Assoc 1993; 202(2): 261-7. 5. Théon AP, Pascoe JR, Madigan JE, Carlson G, Metzger L “Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses” Am J Vet Res 1997; 58(4): 431-6. 6. Goodrich LR, Semevolous SA “How to Prepare and Inject Cisplatin in Oily Emulsion to Treat Equine Sarcoids and Squamous Cell Carcinomas” AAEP Proc 2000: 173-175. 7. Hewes CA, Sullins KE “Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004)” J Am Vet Med Assoc 2006; 229(10): 1617—1622. 8. Hewes CA “How to use Bioabsorbable Cisplatin Beads to Treat Cutaneous 9. Neoplasia” AAEP Proc 2007: 399-402. 10. Wereszka M, personal communication, August 2013   55